March 30, 2017 / 8:37 PM / 4 months ago

BRIEF-Orexigen Therapeutics on March 28, 2017, entered into controlled equity offering sales agreement

1 Min Read

March 30 (Reuters) - Orexigen Therapeutics Inc

* Orexigen Therapeutics Inc- on March 28, 2017, entered into a controlled equity offering sales agreement - sec filing

* Orexigen Therapeutics -under deal co may offer and sell, through agent, shares par value $0.001 per share, with aggregate offering price up to $20 million Source text (bit.ly/2nEXTF7) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below